|
Study Evaluates Safety of Three-Month Versus Standard Twelve-Month Dual Antiplatelet Therapy in Patients with Acute Coronary Syndrome Treated with a Drug-Eluting Stent
|
|
Study Finds Six Months of Dual Antiplatelet Therapy May be Non-Inferior to Twelve Months in STEMI Patients Receiving Drug-Eluting Stents
|
|
Synergy Stent with Shorter DAPT is Superior to a Bare-Metal Stent in Elderly Patients
|
|
Thirty-Day Results of ABSORB IV Demonstrate that Improvements in Bioresorbable Stent Technology and Technique are Still Needed
|
|
TAVR Found to be Cost-effective Compared with SAVR in Intermediate Risk Patients with Aortic Stenosis
|
|
Double Kissing Crush Two-Stent Technique in Left Main Bifurcation Lesions Demonstrates Lower Rates of Target Lesion Failure
|
|
Patients with Left Main Disease Treated with PCI or CABG Experience Significant and Similar Quality of Life Improvement after Three Years
|
|
Should Patients with Cardiogenic Shock Receive Culprit Lesion Only PCI or Multivessel PCI?
|
|
Second Issue of Structural Heart: The Journal of the Heart Team is Now Available
|
|
TCT 2017 Master Clinical Operator Award to Be Presented to Alec Vahanian, MD
|
